Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma

NCT00611624 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00611624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00611624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2006
Completion date
April 30, 2013
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms